Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D.For years, the controversy surrounding the 340B Drug Pricing Program has centered on hos…
The WeekSTAT News ↗
The White House has proposed sweeping changes to the bedrock regulation undergirding all federal contracts, em…
The WeekBioPharma Dive ↗
The funding deal is a vote of confidence in the sales potential of multiple prospects in late-stage developmen…
The WeekPharmaVoice ↗
While rivals scramble to replace lost revenue, Lilly is opening an unprecedented gap by being a "contrarian," …
The WeekFiercePharma ↗
Skin quality affects quality of life for 85% of people, leaving more than one-third of individuals feeling sel…
The WeekFierceBiotech ↗
Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipi…
The WeekBriefing
Anthropic’s CEO urged realism on AI drug discovery as Medicare floated sharp 340B payment cuts, setting diverg…
The WeekSTAT News ↗
Read the 5 key takeaways from STAT's series "Out of Pocket, Out of Reach," an examination of workplace health …
The WeekBioPharma Dive ↗
The California drugmaker, which has collaborations in place with Biogen, Sanofi and Eli Lilly, could be the 14…
The WeekPharmaVoice ↗
As Greater Boston's biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming h…
The WeekFiercePharma ↗
After a site visit by FDA inspectors yielded a Form 483 for Genzyme Ireland in early 2026, the Sanofi subsidia…
The WeekFierceBiotech ↗
Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront to buy Myricx…
The WeekBriefing
The FDA has granted premarket approval to United Therapeutics' LungFX device, designed to assess donor lungs f…
The WeekPharmaceutical Technology ↗
Roche's breast cancer agreement with Astex is one of several oncology deals the Swiss pharma giant has inked i…
The WeekSTAT News ↗
Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this…
The WeekFiercePharma ↗
Contract manufacturing powerhouse Lonza is growing in more ways than one. The Swiss company revealed this week…
The WeekFierceBiotech ↗
United Therapeutics has paid $140 million to buy Thymmune Therapeutics for preclinical regenerative cell thera…
The WeekBriefing
China’s approval of a CAR‑T for solid tumors breaks a scientific barrier and raises pressure on U.S. developer…
The WeekFiercePharma ↗
Nominate up-and-coming early-career pharma marketing pros here to be featured in Fierce's "Rising Stars" Q&…
The WeekFierceBiotech ↗
AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese bi…
The WeekBriefing
The FDA posted an updated list of all approved ANDAs with Competitive Generic Therapy designation, including e…
The WeekFiercePharma ↗
The ad uses hand-crafted puppets to portray sight-based frustrations for those with presbyopia, a common condi…
The WeekFierceBiotech ↗
Roche's investigational KRAS G12C inhibitor has beaten Amgen's Lumakras and Bristol Myers Squibb's Krazati in …
The WeekBriefing
CMS is again proposing reduced Medicare payments for 340B drugs, reopening a long fight over hospital margins …
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.